Head-to-head · Cost-Efficiency Index
Science & Co vs MyFastRx
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Science & Co
A twelve-month committer, or someone who values a company stating plainly what it is and is not.
Visit Science & CoMyFastRx
Cost-first shoppers who want cash-pay shoppers comfortable prepaying several months upfront to reach the lowest per-month compounded-GLP-1 rate on the market.
Visit MyFastRxThe verdict
Science & Co takes it, leading the Cost-Efficiency Index 74 to 73. Declares in its own footer that it is not a compounding facility, and explains its own asterisk in its own FAQ — two disclosures most of this market never makes. MyFastRx still earns a C — Cost-first shoppers who want cash-pay shoppers comfortable prepaying several months upfront to reach the lowest per-month compounded-GLP-1 rate on the market.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Science & Co.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Science & Co | MyFastRx |
|---|---|---|
| Cost-Efficiency Index | 74/100 | 73/100 |
| Semaglutide / mo | $149/mo month-to-month; $79 only on a twelve-month plan | $139/mo (all doses, promotional rate, compounded) |
| Tirzepatide / mo | $199/mo month-to-month; $125 only on a twelve-month plan | $199/mo (all doses, promotional rate, compounded) |
| Semaglutide / yr (modeled) | $1,788 | $1,668 |
| Tirzepatide / yr (modeled) | $2,388 | $2,388 |
| Coverage | Not disclosed | All 50 states |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #62 | #68 |
Science & Co
74/100Where the value is
- States twice in its footer that "Science and Co, Inc. is not a 503A or 503B compounding facility"
- Its own FAQ names the commitment behind the headline: "Plans start at $79 a month on the 12 month plan"
- The printed saving corroborates the reference price — 79 divided by 149 is 53%, exactly the "Save 47%" shown
The tradeoffs
- The number it leads with is a twelve-month commitment; the per-month rates are $149 and $199
- Only two figures are published per drug, so a three- or six-month plan cannot be priced without starting an intake
MyFastRx
73/100Where the value is
- Publishes a full, specific price ladder (1/3/6/12-month) rather than a single vague 'starting at' figure
- LegitScript certified
- Flat pricing across all doses — no dosage upcharges as you titrate
The tradeoffs
- The true no-commitment monthly rate ($139 sema / $199 tirz) is meaningfully higher than the deep prepay-bundle rates the marketing emphasizes ($79-99 / $124-166) — those low numbers require paying for 3, 6, or 12 months upfront
- The lowest first-month price ($69 / $129) requires entering a promo code and applies to one month only
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.